Unlike some lower vertebrates which can completely regenerate their heart, the human heart is a terminally differentiated organ. Cardiomyocytes lost during cardiac injury and heart failure cannot be replaced due to their limited proliferative capacity. Therefore, cardiac injury generally leads to progressive failure. Here, we summarize the latest progress in research on methods to induce cardiomyocyte cell cycle entry and heart repair through the alteration of cardiomyocyte plasticity, which is emerging as an effective strategy to compensate for the loss of functional cardiomyocytes and improve the impaired heart functions
Heart regeneration via stem cell therapy could improve the functional outcome for millions of patien...
Cell-based therapies hold promise of repairing an injured heart, and the description of stem and pro...
Myocardial infarction (MI) is the leading cause of death in the western world. After occlusion of a ...
Abstract Cardiovascular diseases such as myocardial infarction (MI) is a major contributor to human ...
Cardiac diseases such as myocardial infarction (MI) can lead to adverse remodeling and impaired cont...
Many forms of cardiac disease are characterized by cardiomyocyte death due to necrosis, apoptosis an...
The human heart does not regenerate. Instead, following injury, human hearts scar. The loss of contr...
International audienceCardiac diseases, characterized by cardiomyocyte loss, lead to dramatic impair...
AbstractCardiomyocyte proliferation and progenitor differentiation are endogenous mechanisms of myoc...
Despite considerable efforts carried out to develop stem/progenitor cell-based technologies aiming a...
Cardiomyocyte proliferation and progenitor differentiation are endogenous mechanisms of myocardial d...
Cardiovascular disease remains the primary cause of death in the United States and in most nations w...
The limited ability of mammalian adult cardiomyocytes to proliferate following an injury to the hear...
Cell therapy is an exciting option for repairing the injured heart, one that has attracted considera...
Cardiac repair following myocardial injury is restricted due to the limited proliferative potential ...
Heart regeneration via stem cell therapy could improve the functional outcome for millions of patien...
Cell-based therapies hold promise of repairing an injured heart, and the description of stem and pro...
Myocardial infarction (MI) is the leading cause of death in the western world. After occlusion of a ...
Abstract Cardiovascular diseases such as myocardial infarction (MI) is a major contributor to human ...
Cardiac diseases such as myocardial infarction (MI) can lead to adverse remodeling and impaired cont...
Many forms of cardiac disease are characterized by cardiomyocyte death due to necrosis, apoptosis an...
The human heart does not regenerate. Instead, following injury, human hearts scar. The loss of contr...
International audienceCardiac diseases, characterized by cardiomyocyte loss, lead to dramatic impair...
AbstractCardiomyocyte proliferation and progenitor differentiation are endogenous mechanisms of myoc...
Despite considerable efforts carried out to develop stem/progenitor cell-based technologies aiming a...
Cardiomyocyte proliferation and progenitor differentiation are endogenous mechanisms of myocardial d...
Cardiovascular disease remains the primary cause of death in the United States and in most nations w...
The limited ability of mammalian adult cardiomyocytes to proliferate following an injury to the hear...
Cell therapy is an exciting option for repairing the injured heart, one that has attracted considera...
Cardiac repair following myocardial injury is restricted due to the limited proliferative potential ...
Heart regeneration via stem cell therapy could improve the functional outcome for millions of patien...
Cell-based therapies hold promise of repairing an injured heart, and the description of stem and pro...
Myocardial infarction (MI) is the leading cause of death in the western world. After occlusion of a ...